ピペラジン市場- 世界の産業規模、シェア、動向、機会、予測、原料別（天然、合成）、最終用途別（医薬品、農薬、パーソナルケア＆化粧品、その他）、地域別、競合別、2020～2030年

ピペラジンの世界市場規模は2024年に34億5,000万米ドルで、予測期間中のCAGRは4.44%で2030年には44億9,000万米ドルに達すると予測されています。

ピペラジンの世界市場は、医薬品、化学薬品、工業プロセスなど幅広い用途で使用されているため、着実な成長を遂げています。ピペラジンは、2つの窒素原子を含む6員複素環構造を持つ有機化合物で、主に様々な医薬品、樹脂、腐食防止剤の合成中間体として使用されます。ピペラジン誘導体は、特に寄生虫感染症や神経疾患の治療薬として製薬業界で需要が増加しており、市場拡大の原動力となっています。MDPIに掲載された論文によると、ピペラジンは創薬において3番目に普及している窒素ヘテロ環であり、イマチニブ（グリベックとして販売）やシルデナフィル（バイアグラとして販売）を含むいくつかのブロックバスター医薬品の重要な構成要素として機能しています。医薬品化学における広範な応用にもかかわらず、ピペラジンの構造の多様性は依然として限定的であり、ピペラジンを含む医薬品の約80%は窒素位のみに置換基を有します。

ピペラジン市場の主な促進要因の一つは、製薬業界における役割です。クエン酸塩やアジピン酸塩などのピペラジン誘導体は、寄生虫による感染症を治療する駆虫薬として一般的に使用されています。さらに、ピペラジンは、精神科薬や抗炎症薬の合成において重要な中間体として機能します。寄生虫感染症の有病率の上昇と、効果的な医薬品への需要の高まりが、ピペラジンベースの医薬品の消費を押し上げています。また、化学およびポリマー産業への応用も、市場成長を後押しする大きな要因となっています。ピペラジンは、コーティング剤、接着剤、複合材料に不可欠なエポキシ樹脂の製造に使用されています。また、ポリウレタン樹脂やポリアミド樹脂の硬化剤として機能し、機械的特性を向上させます。建設、自動車、航空宇宙産業の成長が、ピペラジンベースの樹脂とポリマーの需要増加に寄与しています。

主な市場促進要因

医薬品需要の増加

主な市場課題

サプライチェーンの混乱と地域依存性

主要市場動向

炭素回収技術に対する需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のピペラジン市場に与える影響

第5章 世界のピペラジン市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • 原料別（天然、合成）
  • 最終用途別（医薬品、農薬、パーソナルケア＆化粧品、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のピペラジン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のピペラジン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のピペラジン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のピペラジン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのピペラジン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• ソースの起動（ある場合）
• 最近の動向

第13章 世界のピペラジン市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• BASF SE
• Dow Inc.
• Evonik Industries AG
• Solvay S.A.
• Albemarle Corporation
• Shell plc
• Huntsman Corporation
• Akzo Nobel N.V.
• Diamines and Chemicals Limited（DACL）
• Shaoxing Xingxin New Materials Co., Ltd

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Piperazine Market was valued at USD 3.45 Billion in 2024 and is expected to reach USD 4.49 Billion by 2030 with a CAGR of 4.44% during the forecast period. The global piperazine market is witnessing steady growth due to its widespread applications in pharmaceuticals, chemicals, and industrial processes. Piperazine, an organic compound with a six-membered heterocyclic structure containing two nitrogen atoms, is primarily used as an intermediate in the synthesis of various drugs, resins, and corrosion inhibitors. The increasing demand for piperazine derivatives, especially in the pharmaceutical industry for the treatment of parasitic infections and neurological disorders, is driving market expansion. According to an article published in MDPI, piperazine is the third most prevalent nitrogen heterocycle in drug discovery and serves as a crucial component in several blockbuster pharmaceuticals, including Imatinib (marketed as Gleevec) and Sildenafil (sold as Viagra). Despite its extensive application in medicinal chemistry, the structural diversity of piperazines remains limited, with approximately 80% of piperazine-containing drugs featuring substituents exclusively at the nitrogen positions.

One of the key drivers of the piperazine market is its role in the pharmaceutical industry. Piperazine derivatives such as citrate and adipate salts are commonly used as anthelmintic drugs to treat infections caused by parasitic worms. Additionally, piperazine serves as a critical intermediate in the synthesis of psychiatric and anti-inflammatory drugs. The rising prevalence of parasitic infections, coupled with an increasing demand for effective medications, has boosted the consumption of piperazine-based pharmaceuticals. Another significant factor fuelling market growth is its application in the chemical and polymer industries. Piperazine is used in the production of epoxy resins, which are essential in coatings, adhesives, and composite materials. Also, it acts as a curing agent in polyurethane and polyamide resins, enhancing their mechanical properties. The growing construction, automotive, and aerospace industries are contributing to the rising demand for piperazine-based resins and polymers.

Key Market Drivers

Rising Demand in Pharmaceuticals

The global piperazine market is witnessing significant growth, primarily driven by its expanding application in the pharmaceutical industry. Piperazine, a versatile chemical compound, is widely used in the synthesis of various pharmaceutical drugs, particularly as an intermediate in producing anthelmintic medications, psychotropic drugs, and anti-tuberculosis treatments. The increasing prevalence of parasitic infections and neurological disorders, coupled with rising healthcare expenditures worldwide, is boosting the demand for piperazine-based pharmaceuticals. In March 2024, The Lancet Neurology published a major study revealing that in 2021, over 3 billion people globally had been living with a neurological condition. The World Health Organization (WHO) contributed to the analysis of the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021 data. The study confirmed that neurological conditions had become the leading cause of ill health and disability worldwide. Additionally, the total burden of disability, illness, and premature mortality-measured in disability-adjusted life years (DALYs)-had increased by 18% since 1990.

Key Market Challenges

Supply Chain Disruptions and Regional Dependencies

The global piperazine market is highly dependent on a few key manufacturing regions, such as China and India, which supply a substantial portion of the world's demand. Disruptions caused by trade restrictions, COVID-19-related lockdowns, or logistical bottlenecks can lead to supply shortages and price spikes. Additionally, reliance on a concentrated production base increases market vulnerability, making diversification a necessity but a challenging endeavor for companies seeking alternative suppliers.

Key Market Trends

Rising Demand for Carbon Capture Technologies

The increasing focus on reducing greenhouse gas emissions has led to significant advancements in carbon capture and storage (CCS) technologies, where piperazine-based solvents are playing a crucial role. As industries face stricter environmental regulations, CCS has emerged as a key strategy to curb CO2 emissions from power plants, industrial facilities, and oil refineries. Piperazine, known for its high reactivity with carbon dioxide, is being increasingly adopted in amine-based CO2 absorption processes to improve efficiency and reduce operational costs. According to the IEA, in 2023, the announced carbon capture capacity for 2030 increased by 35%, while the announced storage capacity grew by 70%. This expansion raised the total projected CO2 capture capacity for 2030 to approximately 435 million tonnes (Mt) per year, with the announced storage capacity reaching around 615 Mt of CO2 annually.

Traditionally, monoethanolamine (MEA) and diethanolamine (DEA) have been the primary solvents used for CO2 capture. However, these solvents often suffer from limitations such as low absorption capacity, high energy consumption for regeneration, and degradation over time. In contrast, piperazine has demonstrated superior reaction kinetics, higher CO2 absorption capacity, and improved thermal stability, making it an attractive alternative. It is commonly used in combination with other amines, such as methyldiethanolamine (MDEA) and MEA, to enhance the overall effectiveness of CO2 capture processes.

Key Market Players

• BASF SE
• Dow Inc.
• Evonik Industries AG
• Solvay S.A.
• Albemarle Corporation
• Shell plc
• Huntsman Corporation
• Akzo Nobel N.V.
• Diamines and Chemicals Limited (DACL)
• Shaoxing Xingxin New Materials Co., Ltd

Report Scope

In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Piperazine Market, By Source:

• Natural
• Synthetic

Piperazine Market, By Application:

• Pharmaceutical
• Agrochemicals
• Personal Care & Cosmetics
• Others

Piperazine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.

Available Customizations:

Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Piperazine Market

5. Global Piperazine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Source (Natural, Synthetic)
  • 5.2.2. By End Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Piperazine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Piperazine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Source
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Piperazine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Source
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Piperazine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Source
      • 6.3.3.2.2. By End Use

7. Europe Piperazine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Piperazine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Source
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Piperazine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Source
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Piperazine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Source
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Piperazine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Source
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Piperazine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Source
      • 7.3.5.2.2. By End Use

8. Asia Pacific Piperazine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Piperazine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Source
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Piperazine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Source
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Piperazine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Source
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Piperazine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Source
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Piperazine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Source
      • 8.3.5.2.2. By End Use

9. South America Piperazine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Piperazine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Source
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Piperazine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Source
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Piperazine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Source
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Piperazine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1. By Source
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Piperazine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Source
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Piperazine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Source
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Piperazine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Source
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Source Launches (If Any)
• 12.3. Recent Developments

13. Global Piperazine Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. BASF SE
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Dow Inc.
• 15.3. Evonik Industries AG
• 15.4. Solvay S.A.
• 15.5. Albemarle Corporation
• 15.6. Shell plc
• 15.7. Huntsman Corporation
• 15.8. Akzo Nobel N.V.
• 15.9. Diamines and Chemicals Limited (DACL)
• 15.10. Shaoxing Xingxin New Materials Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer